Panarum manufactures and commercializes Proteoral excipient for oral proteins, replacing injections.
Panarum's investors include Draper Cygnus, Draper Startup House Ventures, Johnson & Johnson Foundation.
Panarum is headquartered in Newark, United States.
Panarum manufactures and commercializes Proteoral excipient for oral proteins, replacing injections.
Panarum is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Panarum — Funding & Investors." VCBacked, February 18, 2025, https://www.vcbacked.co/company/panarum. Accessed September 30, 2026.
VCBacked. (2025). Panarum — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/panarum
{{cite web |title=Panarum — Funding & Investors |url=https://www.vcbacked.co/company/panarum |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated